Chen Hongmei, Zhu Jin
Department of Gynaecology and Obstetrics, Jing'an District Centre Hospital of Shanghai, Shanghai, China.
Department of Gynaecology and Obstetrics, Gynecology Hospital of Fudan University, Shanghai, China.
J Obstet Gynaecol Res. 2018 Mar;44(3):556-565. doi: 10.1111/jog.13534. Epub 2017 Dec 14.
The FokI polymorphism (C>T, rs2228570) of the vitamin D receptor gene is a coding nonsynonymous single nucleotide polymorphism in the translational initiation codon reported to have functional significance. Although the role of rs2228570 in the risk of ovarian cancer has been widely researched, the association is still unclear. We performed an updated meta-analysis to clarify this issue.
Eligible studies were retrieved from electronic databases for the period 2007-2016. The association was measured by unadjusted odds ratio combined with 95% confidence intervals (CIs). Random-effect or fixed-effect models were used according to the heterogeneity of the studies. We further appreciated the strength of evidence according to Venice guidance.
Fourteen studies (4448 cases and 7242 controls) were included in the meta-analysis. Studies were predominantly conducted in Caucasian populations (4152 cases and 6693 controls). A dominant genetic model was determined to be the most appropriate genetic model. Overall meta-analysis showed a fixed-effect odds ratio of 1.14 (95% CI 1.05-1.23) under a dominant model. The fixed-effect odds ratios were 1.12 (95% CI 1.03-1.21) and 1.49 (95% CI 1.06-2.09) in Caucasian and Asian populations, respectively. The strength of the evidence was moderate.
The rs2228570 polymorphism increased the risk of ovarian cancer in Caucasian populations in a dominant genetic model. The role of this polymorphism in the risk of ovarian cancer in Asian populations should be further studied.
维生素D受体基因的FokI多态性(C>T,rs2228570)是翻译起始密码子处的一个编码非同义单核苷酸多态性,据报道具有功能意义。尽管rs2228570在卵巢癌风险中的作用已得到广泛研究,但其关联性仍不明确。我们进行了一项更新的荟萃分析以阐明这一问题。
从2007年至2016年期间的电子数据库中检索符合条件的研究。通过未调整的比值比结合95%置信区间(CIs)来衡量关联性。根据研究的异质性使用随机效应或固定效应模型。我们进一步根据威尼斯指南评估证据的强度。
荟萃分析纳入了14项研究(4448例病例和7242例对照)。研究主要在白种人群中进行(4152例病例和6693例对照)。确定显性遗传模型为最合适的遗传模型。总体荟萃分析显示,在显性模型下,固定效应比值比为1.14(95%CI 1.05 - 1.23)。在白种人和亚洲人群中,固定效应比值比分别为1.12(95%CI 1.03 - 1.21)和1.49(95%CI 1.06 - 2.09)。证据强度为中等。
在显性遗传模型中,rs2228570多态性增加了白种人群患卵巢癌的风险。该多态性在亚洲人群卵巢癌风险中的作用应进一步研究。